Laine Mika, Eskola Markku, Rapola Janne, Airaksinen Juhani
Helsingin yliopistollinen sairaala, kardiologian klinikka.
Duodecim. 2013;129(3):309-15.
While valve surgery is an established form of treatment in significant valvular heart diseases, open heart surgery is not possible for all patients, owing to the risks involved. The incidence of valvular heart diseases increases sharply with age, and it is common that operative risks are overestimated due to age and associated diseases. This review deals with two catheter therapies that are in clinical use for valvular heart diseases: insertion of aortic valve prosthesis through a catheter and treatment of mitral valve insufficiency by clip implantation via the transvenous access.
虽然瓣膜手术是治疗严重瓣膜性心脏病的一种既定治疗方式,但由于存在风险,并非所有患者都能进行心脏直视手术。瓣膜性心脏病的发病率随年龄急剧上升,并且由于年龄和相关疾病,手术风险被高估的情况很常见。本综述涉及两种临床上用于瓣膜性心脏病的导管治疗方法:通过导管插入主动脉瓣假体以及经静脉途径通过夹子植入治疗二尖瓣关闭不全。